presentation the valuation of a healthcare institution english
DESCRIPTION
Lecture held 18 November 2010 in UtrechtTRANSCRIPT
Value Drivers Corporate Finance
Focus on Value – Value in Focus
Lecture the economic value of health care
institutions
18-11-2010
“Fact of Fiction”
1
© 2010 Value Drivers B.V. All rights reserved
1. Introduction - definitions
2. Health care institutions “profit” versus “non for profit”
3. The solution – simulation
4. Example – value calculation
5. Cost of capital
6. Assessing the market – benchmarking – price and transaction multiples
7. Draft coalition agreement
8. Conclusion
Inhoud
2
© 2010 Value Drivers B.V. All rights reserved
Lecture “economic value of healthcare institutions – 18 November 2010
Confidential
1. Introduction - definitions
Value: Value is the expression in money or otherwise of the meaning
that a certain tangible or intangible asset (or service), or a collection
or complex of such goods has at a certain moment in time for one or
more (potential) stakeholders.
3
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lecture “the economic value of healthcare institutions” – 18 November 2010
1. Introduction - definitions
Economic value is based on the incoming and outgoing cashflows
over which (potential) stakeholder(s) either by propriety, purchase or
sale of a certain tangible or intangible asset (or service) or of a
collection or complex of such assets, or by acquisition or disposal will
have decisive power as from the valuation moment.
Lecture “the economic value of a healthcare institution” – 18 November 2010 4
2. Comparison health care instutution “Profit-
non for profit”
Foundation Regarding the legal status of the foundation
2:285 Civil Code stipulates:
"A foundation is a legal entity which
has no members and seeks the
realization of a idealistic or social goal
which is discribed in the statutes using
a specially designated capital. The goal
may not include the making of
distributions of profits to founders or to
those who are part of its organs, nor to
others, except as the latter, the benefits
have an idealistic or social purpose ".
The legal form of a foundation
constitutes a restriction on the
economic valuation of the operation of
the institution.
Independent treatment
center (ZBC)
It is the intention of the legislator that most
existing commercial structures / ZBC's /
IMSZ are not (yet) allowed to have profit /
distribute profit. It is expected that this
situation will persist for some years.
WTZi
Lecture “the economic value of a
healthcare institution” – 18 November
20105
In principle no “economic value”
2. Comparison healthcare institutions “Profit-
non for profit”
6
© 2010 Value Drivers B.V. All rights reserved
The rules of the “non-for-profit” game:
Distribution mechanism of disposable means. From the expected benefits (available
budgets), the resources are allocated. The remaining balance will be appropriated to the
equity or used for attaining the goal of the association.
A distribution or compensation for capital / risk is not applicable
The distribution of the means without framing causes social dilemmas. Extensive internal
and external regulation is inevitable in order to govern the solution of these dilemmas
appropriately.
Confidential
Lecture “the economic value of a healthcare institution” – 18 November 2010
2. Comparison healthcare institutions “Profit-
non for profit”
Rules of the “profit” game:
The predominant business goal is to generate maximum long term returns. The means are
attributed in such a way that the required returns are realized.
Investment proposals are selected for their contribution to the driving goal of the
organization (maximum returns). Whereas previously the incentives for innovation and
efficiency were limited, now the required return is the driving force of the organization.
Dilemmas in distribution of the means available are solved with financial framing.
Lecture “the economic value of a
healthcare institution” – 18 November
20107
Discounted Cash Flow method, APV-variant (NB: corporate income tax
and taxshield only applicable in the structure of independent
treatment centre (ZBC))
Characteristics
Cash flows
Time preference / future uncertainty
Return / risk
3. The solution - simulation
8
© 2010 Value Drivers B.V. All rights reservedConfidential
Lecture “the economic value of healthcare institutions” – 18 November 2010
3. The solution - simulation
Medium term plan ( prepared by management) and cash flow forecast of the health care
institution–current legal structure without capital expenditure
Medium term plan (prepared by management) and cash flow forecast of the health care institution
– current legal structure with capital expenditure
Medium term plan (prepared by management) and cash flow forecast of the healthcare institution–
(Independent treatment centre) ZBC structure without capital expenditure
Medium term plan (prepared by management) and cash flow forecast of the healthcare institution–
(independent treatment centre) ZBC structure with capital expenditure
Balance sheet positions/working capital forecast
Determination Cost of equity current legal structure versus ZBC structure
Lecture“the valuation of a healthcare
institution” – 18 November 20109
3. The solution – financial modeling from
budget to free cash flow
Lecture “The economic value of a
healthcare institution” – 18 November
2010
10
Stichtingsstructuur ZBC structuur Vrije geldstroom
Begrotinggestuurd winstgestuurd
Baten Omzet Omzet
-/- patientgebonden kosten -/- kostprijs van de omzet -/- kostprijs van de omzet
Exploitatiesaldo Bruto-omzetresultaat Bruto-omzetresultaat
-/- bedrijfskosten -/- bedrijfskosten -/- bedrijfskosten
Bedrijfsresultaat Operationeel resultaat Operationeel resultaat
+/- f inancieel resultaat +/- f inancieel resultaat -/- vennootschapsbelasting
-/- toevoeging vermogen/ -/- vennootschapsbelasting Normatief resultaat
beschikbaar voor doel
+/+ afschrijvingen
-/- investeringen in (im-) materiele vaste activa
+/- mutatie w erkkapitaal
+/- mutatie voorzieningen
Beschikbaar voor uitkering (=0) Netto-resultaat Vrije geldstroom beschikbaar voor vermogensverschaffers
3. The solution – identification value-drivers
Examples value-drivers:
Comparison A-segment versus B-segment
Adherention (predominant by government rule, no influence)
Weighted average number of specialist units (predominant by government rule, no influence)
Production levels
Level of capital expenditure
Interest bearing debt
Legal structure
Lecture “the economic value of
healthcare institutions” – 18 November
201011
4. Example: current legal structure – no capex
12
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lecture “the economic value of healthcare institutions” – 18 November 2010
Geldstroomoverzicht - zonder investering
Ziekenhuis (Stichting) 2009 2010 2011 2012 2013 2014 2015 Na 2015
Bedrijfsresultaat 1.000.000 800.000 550.000 500.000 450.000 400.000 200.000 450.000
+/-Vennootschapsbelasting (normatief) over resultaat 0 0 0 0 0 0 0 0
Bedrijfsresultaat na belasting (NOPLAT) 1.000.000 800.000 550.000 500.000 450.000 400.000 200.000 450.000
+ Afschrijvingen 860.000 1.000.000 1.250.000 1.300.000 1.305.000 1.330.000 1.340.000 1.050.000
- /-Investeringen -890.000 -1.750.000 -975.000 -975.000 -960.000 -950.000 -975.000 -1.050.000
+/-Mutatie w erkkapitaal -1.350.000 40.000 -200.000 75.000 70.000 60.000 25.000 0
VRIJE GELDSTROOM -380.000 90.000 625.000 900.000 865.000 840.000 590.000 450.000
Waardeberekening 2010 2011 2012 2013 2014 2015 Na 2015 Totaal
1 2 3 4 5 6 6
Vrije geldstroom 90.000 625.000 900.000 865.000 840.000 590.000 450.000
Disconteringsfactor 1,1143 1,2417 1,3836 1,5417 1,7180 1,9143 1,9143
Rendementseis eigen vermogen -/- continuerende groeivoet 0,0943
Contante waarde vrije geldstroom 80.768 503.357 650.483 561.058 488.955 308.205 2.492.803 5.085.629
Tax shield (niet van toepassing) 0 0 0 0 0 0 0
Disconteringsfactor
Contant gemaakt belastingvoordeel 0 0 0 0 0 0 0 0
Waarde operationele activiteiten 5.085.629
Marktw aarde vreemd vermogen per 31/12/2009 -5.500.000
Waarde stichtingskapitaal -414.371
Overtollige middelen (excess cash) 150.000
Waarde stichtingskapitaal incl overtollige middelen per 1 januari 2010 -264.371
4. Example: current legal structure – with capex
Lecture “the economic value of
healthcare institutions” – 18 November
2010 13
Geldstroomoverzicht - met investering
Ziekenhuis (Stichting) 2009 2010 2011 2012 2013 2014 2015 Na 2015
Bedrijfsresultaat 1.000.000 800.000 550.000 550.000 600.000 635.000 655.000 668.100
+/-Vennootschapsbelasting (normatief) over resultaat 0 0 0 0 0 0 0 0
Bedrijfsresultaat na belasting (NOPLAT)1.000.000 800.000 550.000 550.000 600.000 635.000 655.000 668.100
+ Afschrijvingen 860.000 1.500.000 2.000.000 2.000.000 2.000.000 2.000.000 2.000.000 2.000.000
- /-Investeringen -890.000 -5.000.000 -1.500.000 -1.600.000 -1.700.000 -1.800.000 -1.900.000 -2.000.000
+/-Mutatie w erkkapitaal -1.350.000 1.500.000 150.000 100.000 50.000 25.000 10.000 0
VRIJE GELDSTROOM -380.000 -1.200.000 1.200.000 1.050.000 950.000 860.000 765.000 668.100
Waardeberekening 2010 2011 2012 2013 2014 2015 Na 2015 Totaal
1 2 3 4 5 6 6
Vrije geldstroom -1.200.000 1.200.000 1.050.000 950.000 860.000 765.000 668.100
Disconteringsfactor 1,114 1,242 1,384 1,542 1,718 1,914 1,914
Rendementseis eigen vermogen -/- continuerende groeivoet 0,0943
Contante waarde vrije geldstroom -1.076.909 966.445 758.897 616.191 500.596 399.621 3.700.982 5.865.823
Tax shield (niet van toepassing) 0 0 0 0 0 0 0
Disconteringsfactor
Contant gemaakt belastingvoordeel 0 0 0 0 0 0 0 0
Waarde operationele activiteiten -1.076.909 966.445 758.897 616.191 500.596 399.621 3.700.982 5.865.823
Marktw aarde vreemd vermogen per 31/12/2009 -5.500.000
Waarde stichtingskapitaal 365.823
Overtollige middelen (excess cash) 150.000
Waarde stichtingskapitaal incl overtollige middelen per 1 januari 2010 515.823
4. Example: ZBC structure – without capex
Lecture “the economic value of
Healthcare institutions” – 18 November
2010 14
Geldstroomoverzicht - ZBC zonder investering
Ziekenhuis (ZBC-structuur) 2009 2010 2011 2012 2013 2014 2015 na 2015
Bedrijfsresultaat 1.000.000 750.000 675.000 550.000 425.000 325.000 200.000 494.000
+/-Vennootschapsbelasting (normatief) over resultaat 0 -180.250 -161.125 -129.250 -97.375 -71.875 -40.000 -114.970
Bedrijfsresultaat na belasting (NOPLAT) 1.000.000 569.750 513.875 420.750 327.625 253.125 160.000 379.030
+ Afschrijvingen 860.000 1.000.000 1.250.000 1.300.000 1.305.000 1.330.000 1.340.000 1.050.000
- /-Investeringen -890.000 -1.750.000 -975.000 -975.000 -960.000 -950.000 -975.000 -1.050.000
+/-Mutatie w erkkapitaal -1.350.000 40.000 -200.000 75.000 70.000 60.000 25.000 0
VRIJE GELDSTROOM -380.000 -140.250 588.875 820.750 742.625 693.125 550.000 379.030
Waardeberekening 2010 2011 2012 2013 2014 2015 Na 2015 Totaal
1 2 3 4 5 6 6
Vrije geldstroom -140.250 588.875 820.750 742.625 693.125 550.000 379.030
Disconteringsfactor 1,1218 1,2584 1,4117 1,5837 1,7765 2,0864 2,0864
Rendementseis eigen vermogen -/- continuerende groeivoet 0,1104
Contante waarde vrije geldstroom -125.022 467.942 581.386 468.930 390.152 263.615 1.645.552 3.692.555
Tax shield 79.778 81.379 76.768 72.864 68.789 64.487 64.487
Disconteringsfactor 1,1218 1,2584 1,4117 1,5837 1,7765 2,0864 2,0864
Rendementseis eigen vermogen -/- continuerende groeivoet 0,1104
Contant gemaakt belastingvoordeel 71.116 64.667 54.380 46.010 38.721 30.909 279.971 585.773
Waarde operationele activiteiten 4.278.328
Marktw aarde vreemd vermogen per 31/12/2009 -5.500.000
Marktwaarde stichtingskapitaal -1.221.672
Overtollige middelen (excess cash) 150.000
Marktwaarde stichtingskapitaal incl overtollige middelen per 1 januari 2010 -1.071.672
4. Example: ZBC structure – with capex
Lecture “the economic value of
healthcare institutions”- 18 November
2010 15
Geldstroomoverzicht - ZBC met investering
Ziekenhuis (ZBC-structuur) 2009 2010 2011 2012 2013 2014 2015 Na 2015
Bedrijfsresultaat 1.000.000 900.000 600.000 650.000 750.000 800.000 825.000 841.500
+/-Vennootschapsbelasting (normatief) over resultaat 0 -218.500 -142.000 -154.750 -180.250 -193.000 -199.375 -203.583
Bedrijfsresultaat na belasting (NOPLAT) 1.000.000 681.500 458.000 495.250 569.750 607.000 625.625 637.918
+ Afschrijvingen 860.000 1.500.000 2.000.000 2.000.000 2.000.000 2.000.000 2.000.000 2.000.000
- /-Investeringen -890.000 -5.000.000 -1.500.000 -1.600.000 -1.700.000 -1.800.000 -1.900.000 -2.000.000
+/-Mutatie w erkkapitaal -1.350.000 1.500.000 150.000 100.000 50.000 25.000 10.000 0
VRIJE GELDSTROOM -380.000 -1.318.500 1.108.000 995.250 919.750 832.000 735.625 637.918
Waardeberekening 2010 2011 2012 2013 2014 2015 Na 2015 Totaal
1 2 3 4 5 6 6
Vrije geldstroom -1.318.500 1.108.000 995.250 919.750 832.000 735.625 637.918
Disconteringsfactor 1,127 1,270 1,431 1,612 1,816 2,142 2,142
Rendementseis eigen vermogen -/- continuerende groeivoet 0,1154
Contante waarde vrije geldstroom -1.170.128 872.662 695.651 570.535 458.025 343.371 2.580.271 4.350.388
Tax shield 113.973 126.670 114.815 103.615 92.243 81.969 81.969
Disconteringsfactor 1,1268 1,2697 1,4307 1,6121 1,8165 2,1424 2,1424
Rendementseis eigen vermogen -/- continuerende groeivoet 0,1154
Contant gemaakt belastingvoordeel 101.148 99.765 80.253 64.274 50.781 38.261 331.550 766.032
Waarde operationele activiteiten 5.116.419
Marktw aarde vreemd vermogen per 31/12/2009 -5.500.000
Waarde stichtingskapitaal -383.581
Overtollige middelen (excess cash) 150.000
Waarde stichtingskapitaal incl overtollige middelen per 1 januari 2010 -233.581
Build Up method – current legal structure:
1. Risk free: yield long government bond per 1 January 2010 (source :FD): 4,18%
2. Market risk: not applicable in current legal structure (0%)
3. Company size premium / specific risks: Dependency staffincl. specialists: 1,5%
Dependency management and board (unanimiteit): 1.25%
Dependency patiënts: 1,5%
Dependency stakeholders (rc en indirect insurer): 1,0%
Dependency (changing) government regulation: 2,0%
Subtotal: 7,25%
4. Total return on equity (unlevered): 11,43%
Continuing growth rate: 2%
Cost of debt: Not applicable for the valuation (no taxshield)
5. Cost of capital
16
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lecture “the valuation of healthcare institutions” – 18 november 2010
Build Up method – Independent treatment center ZBC structure:
1. Risk free: yield long government bond per 1 January 2010 (source :FD): 4,18%
2. Market risk (source:Damodaran): 1,86% (unlevered sectorbeta „healthcare services‟), The market risk is
applicable as from 2015 (assumption is that from 2015 profit distribution is free)
3. Company size premiums / specic risks:
Dependency personnel incl. specialists: 1,5%
Dependency management and board: 1,5%
Dependency patients: 1%
Dependency insurer: 1%
Dependency financers: 2,5% (until 2015), 1,5% after 2015
Dependency (changing) government regulations: 2%
Subtotal: 8,5% (until 2015), 7,5% after 2015
4. Total return on equity (unlevered): 12,68% (until 2015), 13,54% from 2015
Continuerende growth 2%
Cost of debt: 6% (taxshield)
5. Cost of capital
17
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lecture “the valuation of healthcare institutions”– 18 november 2010
6. Benchmarking to the market – price multiples
18
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lecture “the valuation of a healthcare institution” – 18 november 2010
Peergroup 2009
Rentedragende Enterprise Omzet EBITDA EBIT Net Profit Net profit
Company Land Markt kap. schulden Firm value Cash Value Omzet multiple Multiple Multiple Multiples
Mediclin AG Duitsland $205,10 $140,40 $345,50 $89,40 $256,10 $638,30 0,40 6,58 10,41 $9,89 25,9
Athens Medical Center SA Griekenland $162,80 $246,10 $408,90 $21,60 $387,30 $397,80 0,97 8,02 13,88 $15,50 25,0
Care UK plc VK $416,10 $322,50 $738,60 $53,00 $685,60 $655,70 1,05 7,18 13,47 $22,60 30,3
Clínica Baviera, S.A. Spanje $186,50 $35,90 $222,40 $0,00 $222,40 $122,90 1,81 9,31 38,68 $9,80 22,7
Diagnostic & Therapeutic Center of
Athens Hygeia S.A. Griekenland
$386,20 $386,40 $772,60 $0,00 $772,60 $393,80
1,96
11,48 17,40 $29,40
26,3
Eifelhoehen-Klinik AG Duitsland $13,40 $0,00 $13,40 $0,00 $13,40 $54,30 0,25 2,22 3,47 $2,24 6,0
Euromedica SA Griekenland $262,50 $535,60 $798,10 $46,40 $751,70 $320,20 2,35 13,82 17,65 -$19,90 -37,8
Ashley House PLC VK $74,90 $4,73 $79,63 $3,90 $75,73 $35,30 2,15 9,22 9,42 $6,18 12,3
Gemiddelde totaal 1,4 7,5 12,9 4,9
Gemiddelde (Mediclin en Eifelhoehen) 0,3 4,4 6,9 15,9
Medisch Centrum Jan van Goyen (cijfers 2009) 18.497.510 1.709.262 769.433
Prijs gemiddeld 25.156.623 12.790.464 9.893.362
Prijs laagste multiple 4.564.763 3.794.562 2.671.089
Prijs hoogste multiple 43.424.667 23.618.607 29.760.330
Prijs gemiddelde (Mediclin en Eifelhoehen) 5.993.185 7.523.785 5.340.662
Waarde operationele activiteiten:
Huidige structuur met verbouw ing 6.964.839
7. Draft Coalition agreement
19
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lecture “the valuation of a healthcare institution _ 18 November 2010
7. Regeerakkoord
Lecture “the valuation of a healthcare
institution” – 18 November 201020
8. Conclusie
Thinking in cash flows and value, value
creation will take a central role for the
coming years.
Be PREPARED!
21
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lezing “waardebepaling van een zorginstelling – 18 november 2010
Contact:
Value Drivers Corporate Finance
Value Drivers B.V.
Weena 290
Postbus 819
3000 AV ROTTERDAM
The Netherlands
KvK 24.44.22.53
T: +31 (0)10-2821517
F: +31(0)10-2821222
www.value-drivers.nl
22
© 2010 Value Drivers B.V. All rights reservedVertrouwelijk
Lezing “waardebepaling van een zorginstelling” – 18 november 2010